SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 against Mucormycosis at the 11th Advances Against Aspergillosis and Mucormycosis Conference
SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the presentation of preclinical efficacy data on its second generation fungerp candidate SCY-247. Dr. Ashraf Ibrahim, PhD, FAAM, FECCM, Professor…
Venus Remedies gets coveted GMP certification from Libya
Venus Remedies, a globally recognised pharmaceutical company, has been awarded the Good Manufacturing Practices (GMP) certification for its facilities from the Ministry of Health, Libya. This accomplishment is a testament to the company’s commitment to quality, safety and efficiency in…
GM Modular successfully organised Blood Donation Drive ; A demonstration of their service to Mankind
GM Modular, India’s leading electrical solutions manufacturer for modern living, recently organised a successful Blood Donation Drive in collaboration with NayiUdaan Trust on January 12th 2024 in Mumbai from 10am to 5pm. This humanitarian effort inspired many individuals to donate…
New Study Published in JAMA Neurology Affirms High Diagnostic Accuracy of ALZpath’s pTau217 Test in Identifying Amyloid and Tau in the Brain
ALZpath, Inc. (ALZpath), a leader in Alzheimer’s diagnostics, announced new findings published online today in JAMA Neurology showing that its proprietary blood-based biomarker assay for phosphorylated tau at residue 217 (pTau217) delivers high diagnostic accuracy and consistency in identifying amyloid and tau in the brain….
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap
Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced positive topline results from its REPOSE clinical study comparing standard-of-care neurectomy of symptomatic neuroma to neurectomy and protection of the…
Halozyme Announces argenx Received Approval in Japan for VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) Co-Formulated with ENHANZE® for Generalized Myasthenia Gravis
Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that argenx received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) injection co-formulated with Halozyme’s ENHANZE® drug delivery technology for subcutaneous (SC) use for the treatment of adult patients…
Kaia Health Introduces First Comprehensive Digital Pain Management Platform in Spanish, Improving Access to Spanish Speakers in the U.S.
Today, Kaia Health announces an important milestone in its commitment to ensuring affordable and frictionless access to clinically validated digital pain management for all. Developed in collaboration with physical therapists (PTs), health coaches, and Spanish-speaking users, Kaia Health’s signature musculoskeletal…
Indian Drug Manufacturers Association Organises Pharma Live Expo & Summit
The Pharma Live Expo & Summit, organized by the Indian Drug Manufacturers’ Association, ignites the future of the pharma industry. This electrifying event promises three days of inspiration, collaboration, and limitless potential at the Bombay Exhibition Centre, Nesco Mumbai, from…
Kexing Biopharm Introduces Eribulin Mesylate Injection, Expanding Its Overseas Product Portfolio
On the morning of January 3, Kexing Biopharm signed an international commercialization cooperation agreement on Eribulin Mesylate Injection, securing exclusive commercialization licensing and supply of the product from Xiling Lab Co., Ltd. in 36 countries. This is the fifth major breast cancer…
Mindful Therapy Group Expands Leadership Team to Drive Innovation & Support Growth
Mindful Therapy Group (Mindful), a collaborative network of over 1,000 licensed, independent mental health clinicians, today announced the addition of two new executive leaders. Stephen Oshyn joins as Vice President of Growth & Strategy and Jason Wilensky, MBA, joins as Vice President…
